SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-19-000022
Filing Date
2019-09-09
Accepted
2019-09-09 08:16:23
Documents
2
Period of Report
2019-09-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20190909x8k.htm 8-K 37782
2 EX-99.1 bpmx-20190909ex9918c51b1.htm EX-99.1 296241
  Complete submission text file 0001504167-19-000022.txt   335198
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 191081172
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1